סרטיקן ® 0.25 מ"ג טבליות מסיסות

Krajina: Izrael

Jazyk: hebrejčina

Zdroj: Ministry of Health

Aktívna zložka:

EVEROLIMUS 0.25 MG

Dostupné z:

NOVARTIS PHARMA SERVICES AG

ATC kód:

L04AA18

Forma lieku:

TABLETS DISPERSIBLE

Spôsob podávania:

PER OS

Výrobca:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapeutické skupiny:

EVEROLIMUS

Terapeutické indikácie:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Dátum Autorizácia:

2010-02-01